Drugs / Fibrin Sealant Vapor-Heated Solvent/Detergent-treated
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00161902 | Aug 2001 → Mar 2003 | — | Baxter Healthcare Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fibrin Sealant Vapor-Heated Solvent/Detergent-treated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00161902 ↗ |
| Known as | FS VH S/D | “The purpose of the study is to monitor the safety of FS VH S/D and evaluate whether FS VH S/D is superior to standard treatment in reducing blood loss in subjects undergoing...” NCT00161902 ↗ |